These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34258160)

  • 21. Validation of a multiprotein plasma classifier to identify benign lung nodules.
    Vachani A; Pass HI; Rom WN; Midthun DE; Edell ES; Laviolette M; Li XJ; Fong PY; Hunsucker SW; Hayward C; Mazzone PJ; Madtes DK; Miller YE; Walker MG; Shi J; Kearney P; Fang KC; Massion PP
    J Thorac Oncol; 2015 Apr; 10(4):629-37. PubMed ID: 25590604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Establishment and validation of multiclassification prediction models for pulmonary nodules based on machine learning.
    Liu Q; Lv X; Zhou D; Yu N; Hong Y; Zeng Y
    Clin Respir J; 2024 May; 18(5):e13769. PubMed ID: 38736274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analytical validation of the Percepta genomic sequencing classifier; an RNA next generation sequencing assay for the assessment of Lung Cancer risk of suspicious pulmonary nodules.
    Johnson MK; Wu S; Pankratz DG; Fedorowicz G; Anderson J; Ding J; Wong M; Cao M; Babiarz J; Lofaro L; Walsh PS; Kennedy GC; Huang J
    BMC Cancer; 2021 Apr; 21(1):400. PubMed ID: 33849470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoantibody Signature Enhances the Positive Predictive Power of Computed Tomography and Nodule-Based Risk Models for Detection of Lung Cancer.
    Massion PP; Healey GF; Peek LJ; Fredericks L; Sewell HF; Murray A; Robertson JF
    J Thorac Oncol; 2017 Mar; 12(3):578-584. PubMed ID: 27615397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Localized thin-section CT with radiomics feature extraction and machine learning to classify early-detected pulmonary nodules from lung cancer screening.
    Tu SJ; Wang CW; Pan KT; Wu YC; Wu CT
    Phys Med Biol; 2018 Mar; 63(6):065005. PubMed ID: 29446758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Value of peripheral blood rare cell EGFR gene amplification detection in the evaluation of benign and malignant pulmonary nodules].
    Li H; Liu XQ; Yan LJ; Liu Y; Zhang JQ; Xiao YN; Li SQ
    Zhonghua Yi Xue Za Zhi; 2024 May; 104(18):1584-1589. PubMed ID: 38742345
    [No Abstract]   [Full Text] [Related]  

  • 27. Non-malignant pathological results from CT-guided biopsy for pulmonary nodules: a predictive model for identifying false-negative results.
    Wang XZ; Wang JY; Meng T; Shi YB; Sun JJ
    J Cardiothorac Surg; 2024 Jun; 19(1):386. PubMed ID: 38926779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic imprinting alterations as effective diagnostic biomarkers for early-stage lung cancer and small pulmonary nodules.
    Zhou J; Cheng T; Li X; Hu J; Li E; Ding M; Shen R; Pineda JP; Li C; Lu S; Yu H; Sun J; Huang W; Wang X; Si H; Shi P; Liu J; Chang M; Dou M; Shi M; Chen X; Yung RC; Wang Q; Zhou N; Bai C
    Clin Epigenetics; 2021 Dec; 13(1):220. PubMed ID: 34906185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrative Multianalytical Model Based on Novel Plasma Protein Biomarkers for Distinguishing Lung Adenocarcinoma and Benign Pulmonary Nodules.
    Zhang X; Ji L; Liu M; Li J; Sun H; Liang F; Zhao Y; Wang Z; Yang T; Wang Y; Si Q; Du R; Dai L; Ouyang S
    J Proteome Res; 2024 Jan; 23(1):277-288. PubMed ID: 38085828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Value of Combined Detection of Cytokines and Tumor Markers in the 
Differential Diagnosis of Benign and Malignant Solitary Pulmonary Nodules].
    Shi J; Liu X; Ming Z; Li W; Lv X; Yang X; Wang Y; Zhang M; Yang S
    Zhongguo Fei Ai Za Zhi; 2021 Jun; 24(6):426-433. PubMed ID: 34157802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of Plasma Proteomics Biomarker's Ability to Distinguish Benign From Malignant Lung Nodules: Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial.
    Silvestri GA; Tanner NT; Kearney P; Vachani A; Massion PP; Porter A; Springmeyer SC; Fang KC; Midthun D; Mazzone PJ;
    Chest; 2018 Sep; 154(3):491-500. PubMed ID: 29496499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pleural effusion supernatant: a reliable resource for cell-free DNA in molecular testing of lung cancer.
    Thakur S; Rathor A; Jain S; Nambirajan A; Khurana S; Malik PS; Jain D
    J Am Soc Cytopathol; 2024; 13(4):291-302. PubMed ID: 38704351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and Validation of Machine Learning-based Model for the Prediction of Malignancy in Multiple Pulmonary Nodules: Analysis from Multicentric Cohorts.
    Chen K; Nie Y; Park S; Zhang K; Zhang Y; Liu Y; Hui B; Zhou L; Wang X; Qi Q; Li H; Kang G; Huang Y; Chen Y; Liu J; Cui J; Li M; Park IK; Kang CH; Shen H; Yang Y; Guan T; Zhang Y; Yang F; Kim YT; Wang J
    Clin Cancer Res; 2021 Apr; 27(8):2255-2265. PubMed ID: 33627492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Computer-aided diagnosis of lung cancer: the effect of training data sets on classification accuracy of lung nodules.
    Gong J; Liu JY; Sun XW; Zheng B; Nie SD
    Phys Med Biol; 2018 Feb; 63(3):035036. PubMed ID: 29311420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosis of pulmonary nodules by DNA methylation analysis in bronchoalveolar lavage fluids.
    Li L; Ye Z; Yang S; Yang H; Jin J; Zhu Y; Tao J; Chen S; Xu J; Liu Y; Liang W; Wang B; Yang M; Huang Q; Chen Z; Li W; Fan JB; Liu D
    Clin Epigenetics; 2021 Oct; 13(1):185. PubMed ID: 34620221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and clinical validation of a circulating tumor DNA test for the identification of clinically actionable mutations in nonsmall cell lung cancer.
    Liu L; Liu H; Shao D; Liu Z; Wang J; Deng Q; Tang H; Yang H; Zhang Y; Qiu Y; Cui F; Tan M; Zhang P; Li Z; Liu J; Liang W; Wang Y; Peng Z; Wang J; Yang H; Mao M; Kristiansen K; Ye M; He J
    Genes Chromosomes Cancer; 2018 Apr; 57(4):211-220. PubMed ID: 29277949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Novel Diagnosis Method Based on Methylation Analysis of SHOX2 and Serum Biomarker for Early Stage Lung Cancer.
    Huang W; Huang H; Zhang S; Wang X; Ouyang J; Lin Z; Chen P
    Cancer Control; 2020; 27(1):1073274820969703. PubMed ID: 33167712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ultra-deep next-generation sequencing of plasma cell-free DNA in patients with advanced lung cancers: results from the Actionable Genome Consortium.
    Li BT; Janku F; Jung B; Hou C; Madwani K; Alden R; Razavi P; Reis-Filho JS; Shen R; Isbell JM; Blocker AW; Eattock N; Gnerre S; Satya RV; Xu H; Zhao C; Hall MP; Hu Y; Sehnert AJ; Brown D; Ladanyi M; Rudin CM; Hunkapiller N; Feeney N; Mills GB; Paweletz CP; Janne PA; Solit DB; Riely GJ; Aravanis A; Oxnard GR
    Ann Oncol; 2019 Apr; 30(4):597-603. PubMed ID: 30891595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preoperative diagnosis of malignant pulmonary nodules in lung cancer screening with a radiomics nomogram.
    Liu A; Wang Z; Yang Y; Wang J; Dai X; Wang L; Lu Y; Xue F
    Cancer Commun (Lond); 2020 Jan; 40(1):16-24. PubMed ID: 32125097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis of Benign and Malignant Pulmonary Ground-Glass Nodules Using Computed Tomography Radiomics Parameters.
    Liang L; Zhang H; Lei H; Zhou H; Wu Y; Shen J
    Technol Cancer Res Treat; 2022; 21():15330338221119748. PubMed ID: 36259167
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.